Study of ACTR087 in Subjects With Relapsed or Refractory B-cell Lymphoma
Clinical trial NCT02776813 · COMPLETED
Trial details
- NCT number
- NCT02776813
- Sponsor
- Cogent Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2020-02-12
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.